| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| GC38066-50mg |
|
170569-88-7 |
Mavacoxib - Glpbio |
0 | 需詢價 | C16H11F4N3O2S | |
| GC38066-25mg |
|
170569-88-7 |
Mavacoxib - Glpbio |
0 | 需詢價 | C16H11F4N3O2S | |
| GC38066-10mg |
|
170569-88-7 |
Mavacoxib - Glpbio |
0 | 需詢價 | C16H11F4N3O2S | |
| GC38066-5mg |
|
170569-88-7 |
Mavacoxib - Glpbio |
0 | 需詢價 | C16H11F4N3O2S | |
| GC38066-1mg |
|
170569-88-7 |
Mavacoxib - Glpbio |
0 | 需詢價 | C16H11F4N3O2S | |
| GC38065-10mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) - Glpbio |
0 | 需詢價 | C50H71F3N10O9 | |
| GC38065-5mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) - Glpbio |
0 | 需詢價 | C50H71F3N10O9 | |
| GC38065-1mg |
|
— |
Cardiotoxin Analog (CTX) IV (6-12) (TFA) - Glpbio |
0 | 需詢價 | C50H71F3N10O9 | |
| GC38063-100mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38063-50mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38063-25mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38063-10mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38063-5mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38063-1mg |
|
900308-84-1 |
SEC inhibitor KL-1 - Glpbio |
0 | 需詢價 | C18H16ClNO4 | |
| GC38062-10mg |
|
173932-75-7 |
Gambogenic acid - Glpbio |
0 | 需詢價 | C38H46O8 | |
| GC38062-5mg |
|
173932-75-7 |
Gambogenic acid - Glpbio |
0 | 需詢價 | C38H46O8 | |
| GC38062-1mg |
|
173932-75-7 |
Gambogenic acid - Glpbio |
0 | 需詢價 | C38H46O8 | |
| GC38060-100mg |
|
914805-33-7 |
Shield-1 - Glpbio |
0 | 需詢價 | C42H56N2O10 | |
| GC38060-50mg |
|
914805-33-7 |
Shield-1 - Glpbio |
0 | 需詢價 | C42H56N2O10 | |
| GC38060-25mg |
|
914805-33-7 |
Shield-1 - Glpbio |
0 | 需詢價 | C42H56N2O10 | |
小泰
|
010-60710855
|